Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The myofibroblast, a key cell in normal and pathological tissue repair.

Identifieur interne : 002E83 ( Ncbi/Curation ); précédent : 002E82; suivant : 002E84

The myofibroblast, a key cell in normal and pathological tissue repair.

Auteurs : Ian A. Darby [Australie] ; Noraina Zakuan [Australie] ; Fabrice Billet [France] ; Alexis Desmoulière [France]

Source :

RBID : pubmed:26681260

Descripteurs français

English descriptors

Abstract

Myofibroblasts are characterized by their expression of α-smooth muscle actin, their enhanced contractility when compared to normal fibroblasts and their increased synthetic activity of extracellular matrix proteins. Myofibroblasts play an important role in normal tissue repair processes, particularly in the skin where they were first described. During normal tissue repair, they appear transiently and are then lost via apoptosis. However, the chronic presence and continued activity of myofibroblasts characterize many fibrotic pathologies, in the skin and internal organs including the liver, kidney and lung. More recently, it has become clear that myofibroblasts also play a role in many types of cancer as stromal or cancer-associated myofibroblast. The fact that myofibroblasts are now known to be key players in many pathologies makes understanding their functions, origin and the regulation of their differentiation important to enable them to be regulated in normal physiology and targeted in fibrosis, scarring and cancer.

DOI: 10.1007/s00018-015-2110-0
PubMed: 26681260

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:26681260

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The myofibroblast, a key cell in normal and pathological tissue repair.</title>
<author>
<name sortKey="Darby, Ian A" sort="Darby, Ian A" uniqKey="Darby I" first="Ian A" last="Darby">Ian A. Darby</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Medical Sciences, RMIT University, Bundoora, Melbourne, VIC, 3083, Australia. ian.darby@rmit.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Medical Sciences, RMIT University, Bundoora, Melbourne, VIC, 3083</wicri:regionArea>
<wicri:noRegion>3083</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zakuan, Noraina" sort="Zakuan, Noraina" uniqKey="Zakuan N" first="Noraina" last="Zakuan">Noraina Zakuan</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Medical Sciences, RMIT University, Bundoora, Melbourne, VIC, 3083, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Medical Sciences, RMIT University, Bundoora, Melbourne, VIC, 3083</wicri:regionArea>
<wicri:noRegion>3083</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Billet, Fabrice" sort="Billet, Fabrice" uniqKey="Billet F" first="Fabrice" last="Billet">Fabrice Billet</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Physiology, Faculty of Pharmacy, University of Limoges, 2 rue du Dr. Marcland, 87025, Limoges Cedex, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Physiology, Faculty of Pharmacy, University of Limoges, 2 rue du Dr. Marcland, 87025, Limoges Cedex</wicri:regionArea>
<wicri:noRegion>87025, Limoges Cedex</wicri:noRegion>
<wicri:noRegion>87025, Limoges Cedex</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Desmouliere, Alexis" sort="Desmouliere, Alexis" uniqKey="Desmouliere A" first="Alexis" last="Desmoulière">Alexis Desmoulière</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Physiology, Faculty of Pharmacy, University of Limoges, 2 rue du Dr. Marcland, 87025, Limoges Cedex, France. alexis.desmouliere@unilim.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Physiology, Faculty of Pharmacy, University of Limoges, 2 rue du Dr. Marcland, 87025, Limoges Cedex</wicri:regionArea>
<wicri:noRegion>87025, Limoges Cedex</wicri:noRegion>
<wicri:noRegion>87025, Limoges Cedex</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26681260</idno>
<idno type="pmid">26681260</idno>
<idno type="doi">10.1007/s00018-015-2110-0</idno>
<idno type="wicri:Area/PubMed/Corpus">002152</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002152</idno>
<idno type="wicri:Area/PubMed/Curation">002126</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002126</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002126</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002126</idno>
<idno type="wicri:Area/Ncbi/Merge">002E83</idno>
<idno type="wicri:Area/Ncbi/Curation">002E83</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The myofibroblast, a key cell in normal and pathological tissue repair.</title>
<author>
<name sortKey="Darby, Ian A" sort="Darby, Ian A" uniqKey="Darby I" first="Ian A" last="Darby">Ian A. Darby</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Medical Sciences, RMIT University, Bundoora, Melbourne, VIC, 3083, Australia. ian.darby@rmit.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Medical Sciences, RMIT University, Bundoora, Melbourne, VIC, 3083</wicri:regionArea>
<wicri:noRegion>3083</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zakuan, Noraina" sort="Zakuan, Noraina" uniqKey="Zakuan N" first="Noraina" last="Zakuan">Noraina Zakuan</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Medical Sciences, RMIT University, Bundoora, Melbourne, VIC, 3083, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Medical Sciences, RMIT University, Bundoora, Melbourne, VIC, 3083</wicri:regionArea>
<wicri:noRegion>3083</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Billet, Fabrice" sort="Billet, Fabrice" uniqKey="Billet F" first="Fabrice" last="Billet">Fabrice Billet</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Physiology, Faculty of Pharmacy, University of Limoges, 2 rue du Dr. Marcland, 87025, Limoges Cedex, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Physiology, Faculty of Pharmacy, University of Limoges, 2 rue du Dr. Marcland, 87025, Limoges Cedex</wicri:regionArea>
<wicri:noRegion>87025, Limoges Cedex</wicri:noRegion>
<wicri:noRegion>87025, Limoges Cedex</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Desmouliere, Alexis" sort="Desmouliere, Alexis" uniqKey="Desmouliere A" first="Alexis" last="Desmoulière">Alexis Desmoulière</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Physiology, Faculty of Pharmacy, University of Limoges, 2 rue du Dr. Marcland, 87025, Limoges Cedex, France. alexis.desmouliere@unilim.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Physiology, Faculty of Pharmacy, University of Limoges, 2 rue du Dr. Marcland, 87025, Limoges Cedex</wicri:regionArea>
<wicri:noRegion>87025, Limoges Cedex</wicri:noRegion>
<wicri:noRegion>87025, Limoges Cedex</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Cellular and molecular life sciences : CMLS</title>
<idno type="eISSN">1420-9071</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Cicatrix (metabolism)</term>
<term>Cicatrix (pathology)</term>
<term>Humans</term>
<term>Myofibroblasts (cytology)</term>
<term>Myofibroblasts (metabolism)</term>
<term>Myofibroblasts (pathology)</term>
<term>Neoplasms (metabolism)</term>
<term>Neoplasms (pathology)</term>
<term>Wound Healing</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Cicatrice (anatomopathologie)</term>
<term>Cicatrice (métabolisme)</term>
<term>Cicatrisation de plaie</term>
<term>Humains</term>
<term>Myofibroblastes (anatomopathologie)</term>
<term>Myofibroblastes (cytologie)</term>
<term>Myofibroblastes (métabolisme)</term>
<term>Tumeurs (anatomopathologie)</term>
<term>Tumeurs (métabolisme)</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Cicatrice</term>
<term>Myofibroblastes</term>
<term>Tumeurs</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr">
<term>Myofibroblastes</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Myofibroblasts</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Cicatrix</term>
<term>Myofibroblasts</term>
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Cicatrice</term>
<term>Myofibroblastes</term>
<term>Tumeurs</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Cicatrix</term>
<term>Myofibroblasts</term>
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Humans</term>
<term>Wound Healing</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cicatrisation de plaie</term>
<term>Humains</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Myofibroblasts are characterized by their expression of α-smooth muscle actin, their enhanced contractility when compared to normal fibroblasts and their increased synthetic activity of extracellular matrix proteins. Myofibroblasts play an important role in normal tissue repair processes, particularly in the skin where they were first described. During normal tissue repair, they appear transiently and are then lost via apoptosis. However, the chronic presence and continued activity of myofibroblasts characterize many fibrotic pathologies, in the skin and internal organs including the liver, kidney and lung. More recently, it has become clear that myofibroblasts also play a role in many types of cancer as stromal or cancer-associated myofibroblast. The fact that myofibroblasts are now known to be key players in many pathologies makes understanding their functions, origin and the regulation of their differentiation important to enable them to be regulated in normal physiology and targeted in fibrosis, scarring and cancer.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002E83 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 002E83 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:26681260
   |texte=   The myofibroblast, a key cell in normal and pathological tissue repair.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:26681260" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024